Cancer Nanotechnology

Research on nanotechnology cancer therapy extends beyond drug delivery into the creation of new therapeutics available only through use of nanomaterial properties. Although small compared to cells, nanoparticles are large enough to encapsulate many small molecule compounds, which can be of multiple types. At the same time, the relatively large surface area of nanoparticle can be functionalized with ligands, including small molecules, DNA or RNA strands, peptides, aptamers or antibodies. These ligands can be used for therapeutic effect or to direct nanoparticle fate in vivo. These properties enable combination drug delivery, multi-modality treatment and combined therapeutic and diagnostic, known as “theranostic,” action. The physical properties of nanoparticles, such as energy absorption and re-radiation, can also be used to disrupt diseased tissue, as in laser ablation and hyperthermia applications.

  • Diagnostic Methods
  • Drug Delivery
  • Heart Disease
  • Nanorobots & Therapy Methods

Related Conference of Cancer Nanotechnology

July 26-27, 2021

1st Webinar on Pathology

Tokyo, Japan
July 26-27, 2021

1st Pathology

London, UK
August 16-17, 2021

4th World Congress on Pathology and Clinical Practice

Vienna, Austria
August 25-25, 2021

3rd Pathology and Infectious Disease Conference

Paris, France
September 20-21, 2021

19th European Pathology Congress

Paris, France
September 20-21, 2021

Global Pathologists Meet

Manila, Philippines
October 19-20, 2021

World Congress on Pathology and Microbiology

Angeles, Philippines

Cancer Nanotechnology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in